Paysign, Inc. (NASDAQ:PAYS) Shares Purchased by Bard Associates Inc.

Bard Associates Inc. raised its position in Paysign, Inc. (NASDAQ:PAYS) by 19.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,450 shares of the company’s stock after acquiring an additional 5,497 shares during the quarter. Bard Associates Inc. owned approximately 0.06% of Paysign worth $101,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of PAYS. Royce & Associates LP purchased a new position in shares of Paysign in the third quarter valued at approximately $814,000. Barclays PLC lifted its holdings in Paysign by 327.4% during the 3rd quarter. Barclays PLC now owns 47,090 shares of the company’s stock worth $173,000 after buying an additional 36,071 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Paysign by 164.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 63,247 shares of the company’s stock valued at $232,000 after buying an additional 39,299 shares during the period. BNP Paribas Financial Markets increased its position in shares of Paysign by 257.0% during the third quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company’s stock worth $164,000 after acquiring an additional 32,245 shares during the period. Finally, Sanctuary Advisors LLC raised its stake in shares of Paysign by 4.3% in the third quarter. Sanctuary Advisors LLC now owns 121,089 shares of the company’s stock valued at $419,000 after acquiring an additional 5,000 shares in the last quarter. 25.89% of the stock is currently owned by hedge funds and other institutional investors.

Paysign Stock Up 0.8 %

Shares of Paysign stock opened at $2.42 on Wednesday. Paysign, Inc. has a 52-week low of $2.31 and a 52-week high of $5.59. The company has a market capitalization of $129.59 million, a P/E ratio of 16.13 and a beta of 0.93. The company has a 50 day moving average of $2.85 and a 200 day moving average of $3.49.

Wall Street Analyst Weigh In

Separately, Lake Street Capital began coverage on Paysign in a report on Friday, December 20th. They issued a “buy” rating and a $6.00 target price for the company.

Insider Activity

In other news, insider Topline Capital Management, Ll sold 231,187 shares of the company’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $3.31, for a total transaction of $765,228.97. Following the completion of the transaction, the insider now directly owns 5,859,046 shares of the company’s stock, valued at approximately $19,393,442.26. This represents a 3.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Mark Newcomer sold 12,000 shares of the firm’s stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $2.85, for a total value of $34,200.00. Following the sale, the chief executive officer now directly owns 9,036,886 shares in the company, valued at $25,755,125.10. This trade represents a 0.13 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 968,087 shares of company stock worth $3,007,749. 23.30% of the stock is currently owned by corporate insiders.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.